These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 28392422

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An overview and comparison of a recombinant antigen-binding fragment and an antigen-binding fragment from a monoclonal antibody against wogonin glucuronide.
    Paudel MK, Sakamoto S, Tanaka H, Morimoto S.
    J Nat Med; 2017 Oct; 71(4):703-710. PubMed ID: 28623444
    [Abstract] [Full Text] [Related]

  • 3. Development of an immunoassay using an anti-wogonin glucuronide monoclonal antibody.
    Paudel MK, Sakamoto S, Huy LV, Tanaka H, Miyamoto T, Takano A, Morimoto S.
    J Immunoassay Immunochem; 2017 Oct; 38(5):457-470. PubMed ID: 28027008
    [Abstract] [Full Text] [Related]

  • 4. Effect of linker length between variable domains of single chain variable fragment antibody against daidzin on its reactivity.
    Yusakul G, Sakamoto S, Pongkitwitoon B, Tanaka H, Morimoto S.
    Biosci Biotechnol Biochem; 2016 Jul; 80(7):1306-12. PubMed ID: 27116996
    [Abstract] [Full Text] [Related]

  • 5. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
    Kim HS, Tsai S, Zou N, Lo SC, Wear DJ, Izadjoo MJ.
    J Immunol Methods; 2011 Feb 28; 365(1-2):101-9. PubMed ID: 21172353
    [Abstract] [Full Text] [Related]

  • 6. Efficient expression of single chain variable fragment antibody against paclitaxel using the Bombyx mori nucleopolyhedrovirus bacmid DNA system and its characterizations.
    Yusakul G, Sakamoto S, Tanaka H, Morimoto S.
    J Nat Med; 2016 Jul 28; 70(3):592-601. PubMed ID: 26940321
    [Abstract] [Full Text] [Related]

  • 7. Production of a recombinant anti-human CD4 single-chain variable-fragment antibody using phage display technology and its expression in Escherichia coli.
    Babaei A, Zarkesh-Esfahani SH, Gharagozloo M.
    J Microbiol Biotechnol; 2011 May 28; 21(5):529-35. PubMed ID: 21617352
    [Abstract] [Full Text] [Related]

  • 8. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
    Yu F, Wang Y, Xiao Y, He Y, Luo C, Duan D, Li C, Xu S, Xiang T.
    Mol Immunol; 2014 May 28; 59(1):100-9. PubMed ID: 24534066
    [Abstract] [Full Text] [Related]

  • 9. Preparation and Identification of a Single-chain Variable Fragment Antibody Against Canine Distemper Virus.
    Yi L, Cheng S.
    Monoclon Antib Immunodiagn Immunother; 2015 Aug 28; 34(4):228-32. PubMed ID: 26301925
    [Abstract] [Full Text] [Related]

  • 10. A novel variable antibody fragment dimerized by leucine zippers with enhanced neutralizing potency against rabies virus G protein compared to its corresponding single-chain variable antibody fragment.
    Li Z, Cheng Y, Xi H, Gu T, Yuan R, Chen X, Jiang C, Kong W, Wu Y.
    Mol Immunol; 2015 Dec 28; 68(2 Pt A):168-75. PubMed ID: 26325475
    [Abstract] [Full Text] [Related]

  • 11. Bacterial Expression of a Single-Chain Variable Fragment (scFv) Antibody against Ganoderic Acid A: A Cost-Effective Approach for Quantitative Analysis Using the scFv-Based Enzyme-Linked Immunosorbent Assay.
    Yusakul G, Nuntawong P, Sakamoto S, Ratnatilaka Na Bhuket P, Kohno T, Kikkawa N, Rojsitthisak P, Shimizu K, Tanaka H, Morimoto S.
    Biol Pharm Bull; 2017 Dec 28; 40(10):1767-1774. PubMed ID: 28966249
    [Abstract] [Full Text] [Related]

  • 12. Enhancement and Analysis of Human Antiaflatoxin B1 (AFB1) scFv Antibody-Ligand Interaction Using Chain Shuffling.
    Rangnoi K, Choowongkomon K, O'Kennedy R, Rüker F, Yamabhai M.
    J Agric Food Chem; 2018 Jun 06; 66(22):5713-5722. PubMed ID: 29781609
    [Abstract] [Full Text] [Related]

  • 13. Single-chain variable fragment antibody against human aspartyl/asparaginyl beta-hydroxylase expressed in recombinant Escherichia coli.
    Yang H, Wang H, Xue T, Xue XP, Huyan T, Wang W, Song K.
    Hybridoma (Larchmt); 2011 Feb 06; 30(1):69-79. PubMed ID: 21466288
    [Abstract] [Full Text] [Related]

  • 14. Investigation of the structure of anti-human seminal plasma protein single-chain antibody and its association with linker peptide length.
    Jiang X, Zhai J, Song D, Qu Q, Li M, Xing L, Miao S.
    Mol Med Rep; 2015 Sep 06; 12(3):4117-4122. PubMed ID: 26099852
    [Abstract] [Full Text] [Related]

  • 15. Preparation of a single-chain variable fragment and a recombinant antigen-binding fragment against the anti-malarial drugs, artemisinin and artesunate, and their application in an ELISA.
    Paudel MK, Takei A, Sakoda J, Juengwatanatrakul T, Sasaki-Tabata K, Putalun W, Shoyama Y, Tanaka H, Morimoto S.
    Anal Chem; 2012 Feb 21; 84(4):2002-8. PubMed ID: 22260329
    [Abstract] [Full Text] [Related]

  • 16. Development of single-chain Fv against the nucleoprotein of type A influenza virus and its use in ELISA.
    Sengupta D, Shaikh A, Bhatia S, Pateriya AK, Khandia R, Sood R, Prakash A, Pattnaik B, Pradhan HK.
    J Virol Methods; 2014 Nov 21; 208():129-37. PubMed ID: 25152529
    [Abstract] [Full Text] [Related]

  • 17. Study on the relationship between the structure and functions of anti-human cervical cancer single-chain antibody and the lengths of linkers.
    Cheng J, Dul Qx, Zhang, Ren Yf, Zhang Ba, Feng Xd.
    Eur J Gynaecol Oncol; 2016 Nov 21; 37(2):171-7. PubMed ID: 27172740
    [Abstract] [Full Text] [Related]

  • 18. [Construction and application of a lentiviral vector of single-chain variable fragment antibody against human hepatocyte growth factor receptor].
    Chen Y, Guo J, Yin Y, Jiang M, Zhu H, Zhang G, Li B.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Sep 21; 30(9):960-3. PubMed ID: 25200159
    [Abstract] [Full Text] [Related]

  • 19. Preparation and application of a specific single-chain variable fragment against artemether.
    Lu F, Zhang F, Qian J, Huang T, Chen L, Huang Y, Wang B, Cui L, Guo S.
    J Pharm Biomed Anal; 2022 Oct 25; 220():115020. PubMed ID: 36049377
    [Abstract] [Full Text] [Related]

  • 20. Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths.
    Shan D, Press OW, Tsu TT, Hayden MS, Ledbetter JA.
    J Immunol; 1999 Jun 01; 162(11):6589-95. PubMed ID: 10352275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.